BioStem Technologies, Inc. (BSEM)
3.56
+0.06
(+1.71%)
USD |
NASDAQ |
Sep 02, 16:00
3.62
+0.06
(+1.69%)
After-Hours: 20:00
BioStem Technologies Cash from Operations (Annual) : 9.941M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 9.941M |
| December 31, 2024 | 24.46M |
| December 31, 2023 | -3.499M |
| December 31, 2022 | 0.3036M |
| December 31, 2021 | -0.1095M |
| December 31, 2020 | -1.013M |
| December 31, 2019 | -0.8458M |
| December 31, 2018 | -3.660M |
| December 31, 2017 | -1.646M |
| Date | Value |
|---|---|
| December 31, 2016 | -1.694M |
| December 31, 2015 | -0.3536M |
| December 31, 2014 | -0.1855M |
| December 31, 2013 | -0.2778M |
| December 31, 2012 | -0.5874M |
| December 31, 2011 | -0.2739M |
| December 31, 2010 | -0.0718M |
| December 31, 2009 | -0.0153M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Filana Therapeutics, Inc. | -32.25M |
| CorMedix, Inc. | 175.05M |
| Eloxx Pharmaceuticals, Inc. | -6.327M |
| Cannabis Global, Inc. | -0.2899M |
| Breakthrough Chemistry, Inc. | -0.0131M |